Preeti Joshi co-founded Fast Sense Innovations, developing Sep-Scan, a rapid sepsis detection device, aiming to transform ...
Sepsis, a life-threatening condition caused by the body's dysregulated response to infection, remains a leading cause of ...
The Trust acknowledged delays in treatment and admitted that the sepsis pathway was not followed. “Had the sepsis pathway been triggered at triage, intravenous antibiotics would have been ...
Inflammation and coagulation are closely linked in sepsis. Inflammatory mediators generate tissue factor expression and initiate coagulation through activation of the extrinsic pathway ...
The EMBRACE phase 2a trial (NCT06694701) was approved in March 2025. The first trial sites have been initiated, and patient screening to identify eligible patients with IDS has started. The EMBRACE ...